Scarica l'app Stockscreener
0.6125
1.72%
-0.007
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Prophase Labs Inc Borsa (PRPH) Ultime notizie
PRPH (ProPhase Labs) Debt-to-EBITDA : -1.36 (As of Sep. 2024) - GuruFocus.com
ProPhase Labs stock hits 52-week low at $0.61 amid sharp decline - Investing.com Canada
ProPhase Labs Receives Notice from NASDAQ Regarding Minimum Bid Price Requirement On December 26, 2024, ProPhase Labs, Inc. (NASDAQ: PRPH) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC, indicating that t - Defense World
ProPhase Labs faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
ProPhase Labs faces potential Nasdaq delisting over share price - Investing.com
HighTower Advisors LLC Boosts Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline - Investing.com Australia
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline - Investing.com
ProPhase Labs secures private equity backing, nears lozenge deal, and plans cost-cutting measures - MSN
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures - The Manila Times
ProPhase Labs Secures Global Private Equity Backing, Nears - GlobeNewswire
ProPhase Labs Secures Game-Changing Financing Deal, Eyes Major Asian Market Expansion - StockTitan
PRPH (ProPhase Labs) 5-Day RSI : 18.93 (As of Dec. 05, 2024) - GuruFocus.com
ProPhase Labs Launches Genetic Testing Subsidiary with Advanced Technology - Precedence Research
PRPH (ProPhase Labs) Growth Rank : 9 (As of Nov. 26, 2024) - GuruFocus.com
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript - MSN
ProPhase Labs plummets 21%, prices $3M equity offering - MSN
ProPhase Labs 4.17M share Spot Secondary priced at $.72 - MSN
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strat - GuruFocus.com
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... - Yahoo Finance
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... By GuruFocus - Investing.com Canada
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Earnings call: Prophase Labs' Q3 2024 reveals strategic growth initiatives By Investing.com - Investing.com Australia
Arcutis Biotherapeutics (NASDAQ:ARQT) versus ProPhase Labs (NASDAQ:PRPH) Critical Survey - Defense World
ProPhase Labs: Strategic Moves for Future Growth - TipRanks
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 - The Manila Times
ProPhase Labs Announces Closing of Public Offering of Common Stock - GlobeNewswire
Wendys Company (WEN-Q) QuotePress Release - The Globe and Mail
Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
ProPhase Labs to Host Q3 2024 Earnings Call on November 13 | PRPH Stock | PRPH Stock News - StockTitan
ProPhase Labs announces proposed public offering of common stock - MSN
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding - Simply Wall St
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks - Simply Wall St
S&P 500 Tops 6,000; Sezzle Shares Spike Higher - Benzinga
Dow Tops 44,000; US Consumer Sentiment Increases In NovemberNature's Miracle Holding (NASDAQ:NMHI) - Benzinga
U.S. Stock market: FOXO Technologies(+134.66%) Northann Corp.(+67.38%) and ProPhase Labs(-47.43%) were the most volatile stocks during midday trading - Business Upturn
U.S. Stock market: Tivic Health up 138.62%, Northann surges 120.19%, ProPhase Labs down 50.70% among the most volatile stocks during early trading - Business Upturn
PRPHProPhase Labs, Inc. Latest Stock News & Market Updates - StockTitan
ProPhase Labs Prices of Public Offering of Common Stock - citybiz
ProPhase Labs Raises $3M in Public Offering at $0.72 Per Share, Stock Dilution Ahead | PRPH Stock News - StockTitan
ProPhase Labs Announces Pricing of Public Offering of Common Stock - GlobeNewswire
ProPhase Labs plans public stock offering - Investing.com India
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):